At the news
? BULLISHIMPACT 6/10 PRESS-RELEASE filed Aug 3, 2026 at 17:00 ET
BWX Technologies has agreed to sell its medical business to Nordic Capital for up to $800 million, retaining a minority stake. The divestiture allows BWXT to refocus capital and resources on its core nuclear national security and commercial nuclear power markets, while the medical business gains a dedicated healthcare investor.
- BWXT sells its medical business (BWXT Medical and Kinectrics' stable medical isotopes) to Nordic Capital for up to $800 million.
- BWXT will retain a meaningful minority ownership stake in the divested business.
- Transaction expected to close by end of 2026, subject to customary regulatory approvals.
- Sale enables BWXT to concentrate on core nuclear national security and commercial nuclear power growth.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access